Press ReleaseNicox Provides Fourth Quarter 2022 Financial HighlightsNet revenue €1.0 million for fourth quarter 2022, and €3.3 million for the…
Dr Nicco will oversee the development of pipeline across BioSenic’s cell therapy and autoimmune disease platform and will be responsible…
CAMBRIDGE, Mass., Jan. 17, 2023 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc. ® (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on improving…
SHANGHAI, China, Jan. 17, 2023 (GLOBE NEWSWIRE) -- Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences”, HKEX: 1877; SSE: 688180), a…
SHANGHAI, China, Jan. 18, 2023 (GLOBE NEWSWIRE) -- Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences”, HKEX: 1877; SSE: 688180), a…
GUANGZHOU, China, Jan. 17, 2023 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR and LSE: BNR, the “Company” or…
WATERTOWN, Mass., Jan. 17, 2023 (GLOBE NEWSWIRE) -- Lyra Therapeutics, Inc. (Nasdaq: LYRA) (the Company or Lyra), a clinical-stage biotechnology…
Privia’s ACOs expands into Delaware and North CarolinaPrivia’s ACOs now include 2,500+ Independent Providers Serving 191,700+ Medicare Beneficiaries in Medicare…
Privia partners with Beebe Healthcare, a community health system and medical groupACO to participate in 2023 Performance Year with ~12,400…
Realignment of global workforce to deliver annual cost savings, positive cash flow, and focus on innovation programs designed for growth…